ARIPRA aripiprazole 15mg tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
26-11-2017

Toimeaine:

aripiprazole, Quantity: 15 mg

Saadav alates:

Medis Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

aripiprazole

Ravimvorm:

Tablet, uncoated

Koostis:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; hyprolose; maize starch; magnesium stearate

Manustamisviis:

Oral

Ühikuid pakis:

30

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Toote kokkuvõte:

Visual Identification: 7mm, round, biconvex, white uncoated tablets with 15 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2014-10-29